BRCA2 and breast carcinoma: In contrast, the estimated breast cancer relative risk for BRCA2 mutation carriers as compared to population incidence was 17.52 for the age group 30–39 years but virtually constant over age 40 years at around 11–12 (Ptrend=0.697).